
Drug Delivery Market by Oral Drug Delivery (Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery), Device Type (Advanced, Conventional), Distribution Channels, Application - Global Forecast 2024-2030
Description
Drug Delivery Market by Oral Drug Delivery (Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery), Device Type (Advanced, Conventional), Distribution Channels, Application - Global Forecast 2024-2030
The Drug Delivery Market size was estimated at USD 1.72 billion in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.41% to reach USD 2.65 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Drug Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Antares Pharma, Inc. by Halozyme Therapeutics, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Enable Injections, Inc., Gerresheimer AG, Johnson & Johnson Services Inc., Kindeva Drug Delivery, Koninklijke Philips N.V., Merck KGaA, Novartis AG, nsulet Corporation, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..
Market Segmentation & Coverage
This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:
Oral Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Topical Drug Delivery
Device Type
Advanced
Conventional
Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Application
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Drug Delivery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Delivery Market?
3. What are the technology trends and regulatory frameworks in the Drug Delivery Market?
4. What is the market share of the leading vendors in the Drug Delivery Market?
5. Which modes and strategic moves are suitable for entering the Drug Delivery Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Drug Delivery Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing use of biological drugs worldwide
- 5.1.1.2. Swelling demand for effective drug delivery mechanisms
- 5.1.1.3. Significant increase in chronic diseases
- 5.1.2. Restraints
- 5.1.2.1. Increasing drug recalls and drug failures
- 5.1.2.2. Side effects and risk associated with the drugs
- 5.1.3. Opportunities
- 5.1.3.1. Rising demand for cost-effective healthcare treatment
- 5.1.3.2. Growing focus towards home care and self-administration
- 5.1.4. Challenges
- 5.1.4.1. Pricing pressure and issues with patents expiry
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Drug Delivery Market, by Oral Drug Delivery
- 6.1. Introduction
- 6.2. Injectable Drug Delivery
- 6.3. Nasal Drug Delivery
- 6.4. Ocular Drug Delivery
- 6.5. Pulmonary Drug Delivery
- 6.6. Topical Drug Delivery
- 7. Drug Delivery Market, by Device Type
- 7.1. Introduction
- 7.2. Advanced
- 7.3. Conventional
- 8. Drug Delivery Market, by Distribution Channels
- 8.1. Introduction
- 8.2. Hospital Pharmacies
- 8.3. Retail Pharmacies
- 9. Drug Delivery Market, by Application
- 9.1. Introduction
- 9.2. Cancer
- 9.3. Cardiovascular Diseases
- 9.4. Diabetes
- 9.5. Respiratory Diseases
- 10. Americas Drug Delivery Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Drug Delivery Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Drug Delivery Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
- 14.1.2. B. Braun SE
- 14.1.3. Baxter International Inc.
- 14.1.4. Becton, Dickinson and Company
- 14.1.5. Enable Injections, Inc.
- 14.1.6. Gerresheimer AG
- 14.1.7. Johnson & Johnson Services Inc.
- 14.1.8. Kindeva Drug Delivery
- 14.1.9. Koninklijke Philips N.V.
- 14.1.10. Merck KGaA
- 14.1.11. Novartis AG
- 14.1.12. nsulet Corporation
- 14.1.13. OraSure Technologies, Inc.
- 14.1.14. Oxford BioMedica PLC
- 14.1.15. Sanofi S.A.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
- FIGURE 2. DRUG DELIVERY MARKET SIZE, 2023 VS 2030
- FIGURE 3. DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DRUG DELIVERY MARKET DYNAMICS
- FIGURE 7. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2030 (%)
- FIGURE 8. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
- FIGURE 10. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
- FIGURE 12. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.